Objective-To determine the effect of changes in autonomic tone induced by phenylephrine infusion on atrial refractoriness and conduction. Design-Left and right atrial electrophysiological properties were measured before and after a constant phenylephrine infusion designed to increase sinus cycle length by 25%. Subjects-20 patients, aged 53 (SD 6) years, undergoing electrophysiological study for investigation of idiopathic paroxysmal atrial fibrillation (seven patients) or for routine follow up after successful catheter ablation of supraventricular tachycardia (13 patients). Main outcome measures-Changes in left and right atrial effective refractory periods, atrial activation times, and frequency of induction of atrial fibrillation. Results-Phenylephrine (mean dose 69 (SD 18) mg/min) increased mean blood pressure by 22 (12) 22'8 (19.4) ms in the five patients with induced atrial fibrillation after phenylephrine compared to 0 9 (16-2) ms in the 13 patients without induced atrial fibrillation after phenylephrine infusion (P = 0.02).
Design-Left and right atrial electrophysiological properties were measured before and after a constant phenylephrine infusion designed to increase sinus cycle length by 25%. Subjects-20 patients, aged 53 (SD 6) years, undergoing electrophysiological study for investigation of idiopathic paroxysmal atrial fibrillation (seven patients) or for routine follow up after successful catheter ablation of supraventricular tachycardia (13 patients).
Main outcome measures-Changes in left and right atrial effective refractory periods, atrial activation times, and frequency of induction of atrial fibrillation. Results-Phenylephrine (mean dose 69 (SD 18) mg/min) increased mean blood pressure by 22 (12) mm Hg (range 7 to 44) and lengthened sinus cycle length by 223 (94) ms (20 to 430 ). Left atrial effective refractory period lengthened following phenylephrine infusion from 250 (25) to 264 (21) ms (P < 0.001) but there was no significant change in right atrial effective refractory period: 200 (20) v 206 (29), P = 0.11. There was a significant relation between the effect of phenylephrine on sinus cycle length and on right atrial refractoriness (r = 0-6, P = 0 005) with shortening of right atrial refractoriness in patients with the greatest prolongation in sinus cycle length. During phenylephrine infusion, the right atrial stimulus to left atrial activation time at the basic pacing cycle length of 600 ms was unchanged, at 130 (18) v 131 (17) ms, but activation delay with a premature extrastimulus increased: 212 (28) v 227 (38) ms, P = 0-002. Atrial fibrillation was induced by two of 58 refractory period measurements at baseline and by 12 of 61 measurements during phenylephrine infusion (P < 0.01).
Phenylephrine increased the difference between left and right atrial refractory periods by 22'8 (19.4) ms in the five patients with induced atrial fibrillation after phenylephrine compared to 0 9 (16-2) ms in the 13 patients without induced atrial fibrillation after phenylephrine infusion (P = 0.02).
Conclusions-Phenylephrine infusion increased left atrial refractoriness and intra-atrial conduction delay following a premature right atrial extrastimulus. Induction of atrial fibrillation during phenylephrine infusion was associated with non-uniform changes in atrial refractoriness. These data support the concept that changes in autonomic tone may precipitate atrial fibrillation in susceptible individuals.
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In animal models, direct vagal stimulation shortens atrial refractoriness in a non-uniform manner facilitating the induction of atrial fibrillation.'-" Changes in autonomic tone have been linked to the onset of atrial fibrillation in some individuals46 but whether this is a frequent occurrence is uncertain. Vagal stimulation shortens right atrial refractoriness acutely in humans.7 However, the effect of a more sustained increase in vagal tone has not been evaluated. The aim of this study was to determine the effect of a sustained increase in vagal tone induced indirectly by phenylephrine infusion on atrial electrophysiological properties.
Methods

SUBJECTS
Twenty patients who were undergoing electrophysiological study for investigation of idiopathic paroxysmal atrial fibrillation (seven patients) or as routine follow up after successful catheter ablation of supraventricular tachycardia (13 patients) underwent a research study. In the latter patients, catheter ablation had been performed at least three months previously with a median of two radiofrequency applications (mean (SD) 3 5 (4-8) period lengthened consistently following phenylephrine infusion, from 250 (25) to 264 (21) ms (P < 0.001). In contrast, there was no significant change in right atrial effective refractory period (200 (20) v 206 (29), P = 0411), with shortening in seven patients and lengthening in 13. There was a significant relation between the change in sinus cycle length and the change in right atrial refractory period induced by phenylephrine (r = 0-6; P = 0 005) (fig 1) . The change in left atrial refractoriness was not related to the change in sinus cycle length (r = 0 1; P = 0 9 (24) ms. Sustained atrial fibrillation (> 30 cycles) was induced in two patients at baseline and in s data are five patients after phenylephrine (P = NS).
The frequency of induction of atrial fibrillation episodes was increased after phenylephrine infusion. At baseline, atrial fibrillation was induced by two of 58 determinations of right ,as 95 (13) atrial effective refractory period, and after 770 (125) phenylephrine infusion by 12 of 61 right atrial a dose 69 refractory period determinations (P < 0.01).
sure by 22 In no instance, either at baseline or during lengthened phenylephrine infusion, was atrial fibrillation 20 to 430). induced by left atrial stimulation. Phenyllength was ephrine increased the difference between left and right atrial refractory periods by teriods are In animals, direct vagal stimulation shortens refractoriness more in the right than in the left atrium, probably because of the non-uniform distribution of vagal nerve endings.'-' In one study,3 vagal stimulation shortened refractory periods in the right atrial appendage by between 59% and 45% compared to between 16% and 26% in the low posterior left atrium. The change in refractory period in the right atrial appendage was greater than in any of the four left atrial sites sampled. ' Stimulation of the ansae subclaviae also shortens right atrial refractoriness.' Since a constant infusion of phenylephrine results in a decrease in sympathetic outflow"2 as well as an increase in vagal stimulation, the net effect of phenylephrine infusion on atrial refractory period will vary depending upon the relative influence of vagal and adrenergic stimulation."3 Lengthening of atrial refractory periods during phenylephrine infusion, particularly in the left atrium where there is relatively sparse vagal innervation, may be explained by the predominant effects of adrenergic withdrawal.
The results of the animal studies may not be directly comparable to the results of this study. The rise in blood pressure, and the consequent decrease in sinus cycle length induced by phenylephrine, were relatively modest when compared to the animal experiments in which two-to threefold increases in sinus cycle length were obtained by direct vagal stimulation."2As suggested by fig 1, a stronger stimulus (a higher dose of phenylephrine with a target of 30-35% increase in sinus cycle length) may have produced a more consistent shortening of right atrial refractoriness.
An important limitation of this study was the use of phenylephrine to induce reflex changes in autonomic tone. Some of the electrophysiological effects may have resulted from direct a stimulation.'41' In general, however, the direct electrophysiological effects of phenylephrine are relatively minor when compared to the indirect reflex changes. 16'7 Specifically, phenylephrine has no discernible effect on atrial refractoriness in dogs pretreated with nadalol and atropine. '8 A potential limitation may be the effect of previous catheter ablation on the response to phenylephrine. Slow pathway ablation in particular may have significant effects on cardiac autonomic function.'9 These effects, however, resolve within one month of ablation'9 and in this study no major differences were observed in the response of the two groups of patients to phenylephrine infusion.
ATRIAL ARRHYTHMIAS
Although atrial refractory periods did not shorten significantly with phenylephrine infusion, atrial fibrillation was induced more often. This effect was mainly confined to a small number of patients with marked changes in atrial refractoriness (fig 2) . The non-uniform changes in refractoriness in the left and right atria in these patients may have enhanced the induction of atrial fibrillation by increasing the dispersion of repolarisation. 1-3 9-11 20 21 Another potentially important factor was the increase in intra-atrial conduction delay with a premature atrial extrastimulus." The delay in the propagation of a premature impulse to the left atrium may be a manifestation of the increase in left atrial refractory period and increased dispersion of repolarisation." Local block of a premature impulse occurs in areas with delayed restoration of excitability. 23 An increase in intra-atrial conduction delay with premature stimuli is a characteristic finding in patients with idiopathic atrial fibrillation.'s '6 In summary, phenylephrine infusion was associated with non-uniform changes in left and right atrial refractoriness and increased intra-atrial conduction delay following a premature right atrial extrastimulus. Induction of atrial fibrillation was associated with non-uniform changes in atrial refractoriness. These data support the concept that changes in autonomic tone may precipitate atrial fibrillation in susceptible individuals.
